Schaper Benz & Wise Investment Counsel Inc. WI Acquires 5,138 Shares of Plexus Corp. (NASDAQ:PLXS)

Schaper Benz & Wise Investment Counsel Inc. WI lifted its stake in Plexus Corp. (NASDAQ:PLXS - Free Report) by 62.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,346 shares of the technology company's stock after purchasing an additional 5,138 shares during the period. Schaper Benz & Wise Investment Counsel Inc. WI's holdings in Plexus were worth $1,825,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the stock. American Century Companies Inc. grew its stake in Plexus by 204.3% in the second quarter. American Century Companies Inc. now owns 158,032 shares of the technology company's stock worth $16,306,000 after purchasing an additional 106,103 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its position in Plexus by 8.8% during the 2nd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,079,340 shares of the technology company's stock valued at $111,366,000 after acquiring an additional 87,574 shares during the period. Westfield Capital Management Co. LP boosted its stake in Plexus by 28.8% during the first quarter. Westfield Capital Management Co. LP now owns 384,248 shares of the technology company's stock worth $36,434,000 after acquiring an additional 85,986 shares in the last quarter. Vanguard Group Inc. boosted its stake in Plexus by 2.2% during the first quarter. Vanguard Group Inc. now owns 3,515,866 shares of the technology company's stock worth $333,374,000 after acquiring an additional 74,988 shares in the last quarter. Finally, Edgestream Partners L.P. bought a new position in shares of Plexus during the first quarter valued at approximately $3,934,000. Institutional investors own 94.45% of the company's stock.

Insider Buying and Selling

In other Plexus news, Director Karen Marie Rapp sold 500 shares of the firm's stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $128.02, for a total value of $64,010.00. Following the transaction, the director now directly owns 9,586 shares of the company's stock, valued at approximately $1,227,199.72. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Plexus news, insider Steven J. Frisch sold 6,565 shares of the business's stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $128.11, for a total transaction of $841,042.15. Following the completion of the sale, the insider now owns 36,118 shares of the company's stock, valued at approximately $4,627,076.98. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Karen Marie Rapp sold 500 shares of the firm's stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $128.02, for a total value of $64,010.00. Following the completion of the transaction, the director now directly owns 9,586 shares in the company, valued at $1,227,199.72. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,113 shares of company stock valued at $2,541,394 over the last 90 days. Company insiders own 2.39% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on PLXS shares. Benchmark boosted their price target on Plexus from $145.00 to $150.00 and gave the stock a "buy" rating in a research report on Tuesday, October 1st. Needham & Company LLC increased their price objective on shares of Plexus from $114.00 to $144.00 and gave the company a "buy" rating in a research report on Friday, July 26th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $125.25.

Plexus Stock Performance

Shares of NASDAQ PLXS traded down $1.38 during trading on Friday, reaching $138.18. 79,452 shares of the company traded hands, compared to its average volume of 126,734. The firm has a 50 day simple moving average of $129.07 and a 200-day simple moving average of $114.92. Plexus Corp. has a 52-week low of $87.21 and a 52-week high of $139.98. The stock has a market capitalization of $3.79 billion, a PE ratio of 38.17 and a beta of 0.89. The company has a quick ratio of 0.64, a current ratio of 1.47 and a debt-to-equity ratio of 0.07.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its earnings results on Wednesday, July 24th. The technology company reported $1.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.17. The company had revenue of $960.70 million for the quarter, compared to analysts' expectations of $981.32 million. Plexus had a net margin of 2.82% and a return on equity of 9.64%. The firm's quarterly revenue was down 6.0% on a year-over-year basis. During the same quarter last year, the company posted $1.32 earnings per share. Equities research analysts anticipate that Plexus Corp. will post 3.74 earnings per share for the current year.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.